Celtaxsys company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

celtaxsys.com

Celtaxsys has not claimed their Profile.

Want to better differentiate Celtaxsys between your competitors? Show buyers how.

PDS Biotechnology company logo

Why does Celtaxsys win vs. PDS Biotechnology?

Show Celtaxsys's primary competitive advantage

Show Celtaxsys's competitive differentiation

Celtaxsys's alternatives and competitors

See how Celtaxsys compares to similar products. Celtaxsys's top competitors include PDS Biotechnology, Keryx Biopharmaceuticals, and Larimar Therapeutics.

PDS Biotechnology is a company with a growing pipeline of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck ca…

Celtaxsys vs. PDS Biotechnology

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more
  • Keryx Biopharmaceuticals is working to identify medicines to advance the care of people with kidney disease. The company has assembled a concentration of kidney care, i…

    Celtaxsys vs. Keryx Biopharmaceuticals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Larimar Therapeutics (Nasdaq: LRMR) is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, C…

    Celtaxsys vs. Larimar Therapeutics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Versartis is a biotechnology company developing therapeutics for the treatment of endocrine disorders. The company's lead product candidate is VRS-317, a once monthly f…

    Celtaxsys vs. Versartis

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • VLST (Viral Logic Systems Technology) has developed a streamlined and efficient platform that rapidly yields biological therapeutic compositions of matter with a far gr…

    Celtaxsys vs. VLST Corporation

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Taligen Therapeutics is a development-stage biotechnology company.In January 2011, Taligen Therapeutics was acquired by Alexion Pharmaceuticals. The valuation of Talige…

    Celtaxsys vs. Taligen Therapeutics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Logical Therapeutics is an early stage biotechnology company, developing medicines to treat diseases that are associated with poorly controlled or excessive inflammatio…

    Celtaxsys vs. Logical Therapeutics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Halsa Pharmaceuticals is a biotechnology company developing therapeutics for the treatment of obesity, diabetes, cachexia and other metabolic diseases.

    Celtaxsys vs. Halsa Pharmaceuticals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • ASC is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potentia…

    Celtaxsys vs. American Stem Cell

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • ProtAffin is a pre-clinical biotechnology company developing protein-based products countering inflammation. Its biologics targets the heparin-like glycan structures t…

    Celtaxsys vs. ProtAffin

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Kylin Therapeutics, a biotechnology company, employs a RNA nanoparticle technology platform called"pRNA" to exploit the potential of RNA interference (RNAi) for treatme…

    Celtaxsys vs. Kylin Therapeutics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative TLR9 agonist-based products to treat and prevent infectious diseases, alle…

    Celtaxsys vs. Dynavax Technologies Corporation

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • SensiGen is a biotechnology company. They specialize creating tests to screen for diseases more efficiently and quickly. Their goal is to lower the overall costs of dia…

    Celtaxsys vs. SensiGen

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Innodia Inc is a biotechnology company engaged in taking to the market drugs for the treatment of type 2 diabetes and related diseases and in generating value for its s…

    Celtaxsys vs. Innodia

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more

You May Also Like

H
Halsa Pharmaceuticals

Halsa Pharmaceuticals is a biotechnology company developing therapeutics for the treatment of obesity, diabetes, cachexia and other metabolic diseases.

B
Bolder BioTechnology

Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create human protein pharmaceuticals with enhanced therapeutic properties. Most protein pharmaceuticals are rapidly eliminated by the body, which limits their effectiveness and requires that they be administered by frequent, often daily, injection. The company's products are designed to last longer in the body, which aims to allow them to be administered less frequently, e.g., once per week to once per month, and maximizes their therapeutic benefits to patients. Company scientists combine protein structure/function information with targeted protein modification technologies to rationally design long-acting protein pharmaceuticals that, in many cases, are 10-100-fold more potent than competing products prepared using non-targeted protein modification technologies. Bolder BioTechnology has a robust pipeline of products in preclinical development, including products for the treatment of hematological and endocrine disorders, cancer and infectious disease. The company intend to commercialize these products independently and through strategic alliances with corporate partners.

REGiMMUNE Logo
REGiMMUNE

REGiMMUNE is a biotechnology company focused on the discovery, development and commercialization of immune regulatory therapeutics to treat conditions such as allergies, autoimmune diseases and inflammatory disorders.

L
LeukoSight

LeukoSight Inc. is an early stage biotechnology company developing a line of therapeutics that can be used to treat autoimmune and inflammatory diseases.

XOMA Logo
XOMA

XOMA (NASDAQ: XOMA) is a biotechnology company focused on the discovery and development of monoclonal antibody-based therapeutics. The Company is a late-stage biotechnology company with a diverse portfolio of innovative therapeutic antibodies. XOMA's product candidates are the result of developing monoclonal antibodies, which have created new opportunities to potentially treat a wide range of endocrine diseases.

Kylin Therapeutics Logo
Kylin Therapeutics

Kylin Therapeutics, a biotechnology company, employs a RNA nanoparticle technology platform called"pRNA" to exploit the potential of RNA interference (RNAi) for treatment of many common diseases including cancer.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.